Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,010 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-integrin αvβ6 Autoantibodies are Increased in Primary Sclerosing Cholangitis Patients With Concomitant Inflammatory Bowel Disease and Correlate With Liver Disease Severity.
Bloemen H, Livanos AE, Martins A, Dean R, Bravo AC, Bourgonje AR, Tankelevich M, Herb J, Cho J, Santos AA, Rodrigues CMP, Petralia F, Colombel JF, Bowlus CL, Schiano T, Torres J, Levy C, Mehandru S. Bloemen H, et al. Among authors: torres j. Clin Gastroenterol Hepatol. 2024 Oct 25:S1542-3565(24)00969-8. doi: 10.1016/j.cgh.2024.10.005. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39490950
Early Biological Therapy Within 12 Months of Diagnosis Leads to Higher Transmural Healing Rates in Crohn's Disease.
Revés J, Fernandez-Clotet A, Ordás I, Buisson A, Bazoge M, Hordonneau C, Ellul P, D'Anastasi M, Elorza A, Aduna M, Rodríguez-Lago I, Lajas IS, Raimundo A, Bettencourt PJG, Freire G, Sousa P, Primitivo A, Delgado I, Rimola J, Torres J. Revés J, et al. Among authors: torres j. Clin Gastroenterol Hepatol. 2024 Aug 30:S1542-3565(24)00769-9. doi: 10.1016/j.cgh.2024.07.034. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39209193
Non-serious adverse events in patients with ulcerative colitis receiving etrasimod: an analysis of the phase II OASIS and phase III ELEVATE UC 52 and ELEVATE UC 12 clinical trials.
Lees CW, Torres J, Leung Y, Vermeire S, Fellmann M, Modesto I, McDonnell A, Lazin K, Keating M, Goetsch M, Wu J, Loftus EV Jr. Lees CW, et al. Among authors: torres j. Therap Adv Gastroenterol. 2024 Nov 7;17:17562848241293643. doi: 10.1177/17562848241293643. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39526078 Free PMC article.
Search for Fractionally Charged Particles with CUORE.
Adams DQ, Alduino C, Alfonso K, Avignone FT, Azzolini O, Bari G, Bellini F, Benato G, Beretta M, Biassoni M, Branca A, Brofferio C, Bucci C, Camilleri J, Caminata A, Campani A, Cao J, Capelli S, Capelli C, Cappelli L, Cardani L, Carniti P, Casali N, Celi E, Chiesa D, Clemenza M, Copello S, Cremonesi O, Creswick RJ, D'Addabbo A, Dafinei I, Del Corso F, Dell'Oro S, Di Domizio S, Di Lorenzo S, Dixon T, Dompè V, Fang DQ, Fantini G, Faverzani M, Ferri E, Ferroni F, Fiorini E, Franceschi MA, Freedman SJ, Fu SH, Fujikawa BK, Ghislandi S, Giachero A, Girola M, Gironi L, Giuliani A, Gorla P, Gotti C, Guillaumon PV, Gutierrez TD, Han K, Hansen EV, Heeger KM, Helis DL, Huang HZ, Keppel G, Kolomensky YG, Kowalski R, Liu R, Ma L, Ma YG, Marini L, Maruyama RH, Mayer D, Mei Y, Moore MN, Napolitano T, Nastasi M, Nones C, Norman EB, Nucciotti A, Nutini I, O'Donnell T, Olmi M, Oregui BT, Ouellet JL, Pagan S, Pagliarone CE, Pagnanini L, Pallavicini M, Pattavina L, Pavan M, Pessina G, Pettinacci V, Pira C, Pirro S, Pottebaum EG, Pozzi S, Previtali E, Puiu A, Quitadamo S, Ressa A, Rosenfeld C, Schmidt B, Sharma V, Singh V, Sisti M, Speller D, Stark P, Surukuchi PT, Taffarello L, Tomei C, Torres A, … See abstract for full author list ➔ Adams DQ, et al. Among authors: torres ja. Phys Rev Lett. 2024 Dec 13;133(24):241801. doi: 10.1103/PhysRevLett.133.241801. Phys Rev Lett. 2024. PMID: 39750326
4,010 results